Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (59)

2024

  1. Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting

    Annals of Hepatology, Vol. 29, Núm. 5

  2. Hyponatremia after COVID-19 is frequent in the first year and increases re-admissions

    Scientific Reports, Vol. 14, Núm. 1

  3. Impact of percutaneous mitral paravalvular leak closure on the natural history of recurrent gastrointestinal bleeding

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 5, pp. e329-e331

  4. Long-term outcomes (beyond 5 years) of liver transplant recipients-A transatlantic multicenter study

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 30, Núm. 2, pp. 170-181

  5. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

    Journal of Hepatology, Vol. 80, Núm. 6, pp. 904-912

  6. Recurrent alcohol-associated hepatitis is common and is associated with increased mortality

    Hepatology, Vol. 80, Núm. 3, pp. 621-632

  7. Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation

    Frontiers in Immunology, Vol. 15

  8. The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis

    Liver International, Vol. 44, Núm. 2, pp. 279-285

2022

  1. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181

  2. Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

    Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050

  3. Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders

    Viruses, Vol. 14, Núm. 11

  4. High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation

    Clinical and Translational Science, Vol. 15, Núm. 6, pp. 1544-1555

  5. Real-world evidence of sofosbuvir/velpatasvir as an effective and simple hepatitis C virus treatment and elimination tool in homeless populations

    Future Virology, Vol. 17, Núm. 2, pp. 77-86

  6. Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients

    American Journal of Transplantation

  7. Relationship among Streptococcus gallolyticus Subsp. gallolyticus, Enterococcus faecalis and Colorectal Neoplasms in Recurrent Endocarditis: A Historical Case Series

    Journal of Clinical Medicine, Vol. 11, Núm. 8

  8. Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study

    Diagnostics, Vol. 12, Núm. 7

  9. Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study

    Liver Transplantation, Vol. 28, Núm. 7, pp. 1257-1261

  10. Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy

    Annals of Hepatology, Vol. 27, Núm. 3